Therapeutic potential of Ganoderma lucidum polysaccharide peptide in Doxorubicin-induced nephropathy: modulation of renin-angiotensin system and proteinuria.

Ganoderma lucidum

OncologyImmune supportMetabolic healthLiver support

SpeciesReishi, Lingzhi

JournalFrontiers in pharmacology

Year2023

Metadata-grounded summary

Article summary

Metadata-grounded summary: This research article indexes research on Ganoderma lucidum in Frontiers in pharmacology in 2023. MycoData maps the paper to oncology, immune support, metabolic health, liver support based on its title, species context, article metadata, and study classification.

Citation

Fang H, Lin D, Li X, Wang L, Yang T (2023). Therapeutic potential of Ganoderma lucidum polysaccharide peptide in Doxorubicin-induced nephropathy: modulation of renin-angiotensin system and proteinuria. Frontiers in pharmacology https://doi.org/10.3389/fphar.2023.1287908 PMID: 37841924

Open citation